603939 益丰药房
已收盘 12-17 15:00:00
资讯
新帖
简况
益丰药房（603939）披露为控股子公司提供担保的进展公告，12月4日股价下跌0.89%
证券之星 · 12-04
益丰药房（603939）披露为控股子公司提供担保的进展公告，12月4日股价下跌0.89%
益丰药房（603939）披露2022年限制性股票激励计划部分限制性股票回购注销实施公告，11月24日股价下跌1.71%
证券之星 · 11-24
益丰药房（603939）披露2022年限制性股票激励计划部分限制性股票回购注销实施公告，11月24日股价下跌1.71%
每周股票复盘：益丰药房（603939）高管拟合计减持不超21.39万股
证券之星 · 11-23
每周股票复盘：益丰药房（603939）高管拟合计减持不超21.39万股
益丰药房最新公告：高管王永辉、肖再祥合计拟减持不超0.0176%股份
证券之星 · 11-16
益丰药房最新公告：高管王永辉、肖再祥合计拟减持不超0.0176%股份
益丰药房（603939）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 10-31
益丰药房（603939）2025年三季报简析：营收净利润同比双双增长，盈利能力上升
图解益丰药房三季报：第三季度单季净利润同比增长10.14%
证券之星 · 10-29
图解益丰药房三季报：第三季度单季净利润同比增长10.14%
益丰药房（603939）19.68万股限售股将于10月27日解禁，占总股本0.02%
证券之星 · 10-27
益丰药房（603939）19.68万股限售股将于10月27日解禁，占总股本0.02%
每周股票复盘：益丰药房（603939）196,838股限售股10月27日上市
证券之星 · 10-26
每周股票复盘：益丰药房（603939）196,838股限售股10月27日上市
益丰药房（603939）披露2022年限制性股票激励计划预留授予股份第二次解除限售暨上市公告，10月21日股价下跌0.83%
证券之星 · 10-21
益丰药房（603939）披露2022年限制性股票激励计划预留授予股份第二次解除限售暨上市公告，10月21日股价下跌0.83%
每周股票复盘：益丰药房（603939）决定不向下修正转股价格
证券之星 · 10-19
每周股票复盘：益丰药房（603939）决定不向下修正转股价格
益丰药房（603939）披露不向下修正“益丰转债”转股价格的公告，10月15日股价上涨0.12%
证券之星 · 10-15
益丰药房（603939）披露不向下修正“益丰转债”转股价格的公告，10月15日股价上涨0.12%
益丰药房（603939）披露2022年限制性股票激励计划预留授予第二个解除限售期解除限售条件成就公告，9月30日股价上涨0.16%
中金财经 · 09-30
益丰药房（603939）披露2022年限制性股票激励计划预留授予第二个解除限售期解除限售条件成就公告，9月30日股价上涨0.16%
每周股票复盘：益丰药房（603939）将召开2025年半年度业绩说明会
证券之星 · 09-28
每周股票复盘：益丰药房（603939）将召开2025年半年度业绩说明会
每周股票复盘：益丰药房（603939）益丰转债转股价格调整至31.84元
证券之星 · 09-21
每周股票复盘：益丰药房（603939）益丰转债转股价格调整至31.84元
每周股票复盘：益丰药房（603939）每股派息0.30元含税
证券之星 · 09-14
每周股票复盘：益丰药房（603939）每股派息0.30元含税
研报掘金丨中银证券：维持益丰药房“买入”评级，看好公司的长期发展
格隆汇 · 09-12
研报掘金丨中银证券：维持益丰药房“买入”评级，看好公司的长期发展
益丰药房涨5.27%，中邮证券六日前给出“买入”评级
证券之星 · 09-08
益丰药房涨5.27%，中邮证券六日前给出“买入”评级
东吴证券：给予益丰药房买入评级
证券之星 · 09-05
东吴证券：给予益丰药房买入评级
每周股票复盘：益丰药房（603939）2025年中报净利增10.32%
证券之星 · 08-31
每周股票复盘：益丰药房（603939）2025年中报净利增10.32%
国金证券：给予益丰药房买入评级
证券之星 · 08-30
国金证券：给予益丰药房买入评级
加载更多
公司概况
公司名称：
益丰大药房连锁股份有限公司
所属行业：
零售业
上市日期：
2015-02-17
主营业务：
益丰大药房连锁股份有限公司的主营业务是中西成药、中药饮片、医疗器械、保健食品、保健用品、个人护理用品以及与健康相关联的日化便利、家居清洁等商品的全渠道零售业务。公司的主要产品是中西成药、中药、非药品。
发行价格：
19.47
{"stockData":{"symbol":"603939","market":"SH","secType":"STK","nameCN":"益丰药房","latestPrice":21.63,"timestamp":1765954800000,"preClose":21.12,"halted":0,"volume":14296268,"delay":0,"changeRate":0.0241,"floatShares":1212000000,"shares":1212000000,"eps":1.3549,"marketStatus":"已收盘","change":0.51,"latestTime":"12-17 15:00:00","open":21.04,"high":21.75,"low":20.81,"amount":307000000,"amplitude":0.0445,"askPrice":21.63,"askSize":2,"bidPrice":21.62,"bidSize":390,"shortable":0,"etf":0,"ttmEps":1.3549,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766021400000},"marketStatusCode":5,"adr":0,"adjPreClose":21.12,"symbolType":"stock","openAndCloseTimeList":[[1765935000000,1765942200000],[1765947600000,1765954800000]],"highLimit":23.23,"lowLimit":19.01,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1212391897,"isCdr":false,"pbRate":2.39,"roa":"--","peRate":15.964278,"roe":"11.05%","epsLYR":1.26,"committee":0.468454,"marketValue":26224000000,"turnoverRate":0.0118,"status":0,"floatMarketCap":26224000000},"requestUrl":"/m/hq/s/603939","defaultTab":"news","newsList":[{"id":"2588000819","title":"益丰药房（603939）披露为控股子公司提供担保的进展公告，12月4日股价下跌0.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588000819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588000819?lang=zh_cn&edition=full","pubTime":"2025-12-04 17:32","pubTimestamp":1764840726,"startTime":"0","endTime":"0","summary":"截至2025年12月4日收盘，益丰药房报收于23.34元，较前一交易日下跌0.89%，最新总市值为282.97亿元。公司近日发布公告称，益丰大药房连锁股份有限公司为全资子公司江苏益丰大药房连锁有限公司向中信银行股份有限公司南京分行申请20,000.00万元综合授信提供连带责任保证，担保期限自2025年10月28日至2026年10月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120400027349.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","603939","LU1064130708.USD","LU2460026573.USD","LU2148510915.USD","LU1064131003.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2585987704","title":"益丰药房（603939）披露2022年限制性股票激励计划部分限制性股票回购注销实施公告，11月24日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2585987704","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585987704?lang=zh_cn&edition=full","pubTime":"2025-11-24 22:42","pubTimestamp":1763995329,"startTime":"0","endTime":"0","summary":"截至2025年11月24日收盘，益丰药房报收于22.93元，较前一交易日下跌1.71%，最新总市值为278.01亿元。公司近日发布公告称，因5名激励对象离职、降级或绩效不达标，根据《上市公司股权激励管理办法》及公司2022年限制性股票激励计划相关规定，对其已获授但未解除限售的25,516股限制性股票进行回购注销。本次回购注销已于2025年11月27日完成，公司已履行相关决策程序和信息披露义务，并办理股份回购专用账户及过户手续。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112400036444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2460026573.USD","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD","LU2488822045.USD","603939","BK0209"],"gpt_icon":0},{"id":"2585106996","title":"每周股票复盘：益丰药房（603939）高管拟合计减持不超21.39万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2585106996","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585106996?lang=zh_cn&edition=full","pubTime":"2025-11-23 04:45","pubTimestamp":1763844312,"startTime":"0","endTime":"0","summary":"截至2025年11月21日收盘，益丰药房报收于23.33元，较上周的24.88元下跌6.23%。本周，益丰药房11月17日盘中最高价报24.75元。本周关注点公司公告汇总：副总裁王永辉拟减持不超150,300股，副总裁肖再祥拟减持不超63,600股。二人因自身资金需求，拟通过集中竞价方式分别减持不超过150,300股和63,600股，合计不超过213,900股，减持比例均不超过各自持股的25%。减持期间为2025年12月8日至2026年3月7日，股份来源为股权激励及资本公积金转增股本。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112300001386.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU1064130708.USD","BK0209","603939","LU2488822045.USD","LU2460026573.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"2583666943","title":"益丰药房最新公告：高管王永辉、肖再祥合计拟减持不超0.0176%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2583666943","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2583666943?lang=zh_cn&edition=full","pubTime":"2025-11-16 17:40","pubTimestamp":1763286013,"startTime":"0","endTime":"0","summary":"益丰药房(603939.SH)公告称，公司副总裁王永辉计划减持不超过15.03万股，占公司总股本比例不超过0.0124%；副总裁肖再祥计划减持不超过6.36万股，占公司总股本比例不超过0.0052%。减持方式为集中竞价交易，减持原因为自身资金需求，减持期间为2025年12月8日至2026年3月7日。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025111600008682.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","BK0209","LU2488822045.USD","BK0183","LU1064131003.USD","BK0077","603939","BK0196","LU2460026573.USD","BK0170","LU2148510915.USD","601933"],"gpt_icon":0},{"id":"2579109635","title":"益丰药房（603939）2025年三季报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2579109635","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579109635?lang=zh_cn&edition=full","pubTime":"2025-10-31 06:22","pubTimestamp":1761862957,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期益丰药房发布2025年三季报。截至本报告期末，公司营业总收入172.86亿元，同比上升0.39%，归母净利润12.25亿元，同比上升10.27%。按单季度数据看，第三季度营业总收入55.64亿元，同比上升1.97%，第三季度归母净利润3.45亿元，同比上升10.14%。本报告期益丰药房盈利能力上升，毛利率同比增幅0.03%，净利率同比增幅9.81%。持有益丰药房最多的基金为交银新成长混合，目前规模为48.9亿元，最新净值3.351，较上一交易日下跌1.06%，近一年上涨6.28%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100007969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939"],"gpt_icon":0},{"id":"2579597978","title":"图解益丰药房三季报：第三季度单季净利润同比增长10.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579597978","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579597978?lang=zh_cn&edition=full","pubTime":"2025-10-29 18:33","pubTimestamp":1761734000,"startTime":"0","endTime":"0","summary":"证券之星消息，益丰药房2025年三季报显示，前三季度公司主营收入172.86亿元，同比上升0.39%；归母净利润12.25亿元，同比上升10.27%；扣非净利润11.88亿元，同比上升8.8%；其中2025年第三季度，公司单季度主营收入55.64亿元，同比上升1.97%；单季度归母净利润3.45亿元，同比上升10.14%；单季度扣非净利润3.31亿元，同比上升8.08%；负债率54.42%，投资收益9976.95万元，财务费用1.13亿元，毛利率40.41%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102900039319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939"],"gpt_icon":0},{"id":"2578666631","title":"益丰药房（603939）19.68万股限售股将于10月27日解禁，占总股本0.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578666631","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578666631?lang=zh_cn&edition=full","pubTime":"2025-10-27 08:02","pubTimestamp":1761523377,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，益丰药房于10月27日将有19.68万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.02%。本次解禁后，公司还有2.55万股限售股份，占总股本0.0%。益丰药房主营业务：从事中西成药、中药饮片、医疗器械、保健食品、个人护理用品及与健康相关联的日用便利品等商品的连锁零售业务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102700002209.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","603939","BK0209","LU2460026573.USD","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2578507827","title":"每周股票复盘：益丰药房（603939）196,838股限售股10月27日上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2578507827","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578507827?lang=zh_cn&edition=full","pubTime":"2025-10-26 03:37","pubTimestamp":1761421029,"startTime":"0","endTime":"0","summary":"截至2025年10月24日收盘，益丰药房报收于25.21元，较上周的24.7元上涨2.06%。本周，益丰药房10月23日盘中最高价报25.76元。公司已于2025年9月30日召开董事会，审议通过本次解除限售事项，29名激励对象可解除限售股份共计196,838股，占公司总股本的0.02%。限制性股票授予登记完成日为2023年10月25日，第二个解除限售期已于2025年10月24日届满。本次解除限售股份上市流通日为2025年10月27日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102600000803.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","603939","BK0209","LU2148510915.USD","LU2488822045.USD","LU1064130708.USD","LU2460026573.USD"],"gpt_icon":0},{"id":"2577652871","title":"益丰药房（603939）披露2022年限制性股票激励计划预留授予股份第二次解除限售暨上市公告，10月21日股价下跌0.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577652871","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577652871?lang=zh_cn&edition=full","pubTime":"2025-10-21 22:29","pubTimestamp":1761056950,"startTime":"0","endTime":"0","summary":"截至2025年10月21日收盘，益丰药房报收于25.11元，较前一交易日下跌0.83%，最新总市值为304.44亿元。近日，益丰药房发布关于2022年限制性股票激励计划预留授予股份第二次解除限售暨上市的公告。公告显示，本次解除限售的限制性股票数量为196,838股，上市流通日期为2025年10月27日。公司预留授予登记完成日为2023年10月25日，第二个解除限售期已于2025年10月24日届满。本次解除限售后，有限售条件股份减少196,838股，无限售条件股份增加196,838股，总股本不变。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102100037101.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU2460026573.USD","603939","LU2488822045.USD","BK0209","LU2148510915.USD","LU1064130708.USD"],"gpt_icon":0},{"id":"2576904663","title":"每周股票复盘：益丰药房（603939）决定不向下修正转股价格","url":"https://stock-news.laohu8.com/highlight/detail?id=2576904663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576904663?lang=zh_cn&edition=full","pubTime":"2025-10-19 02:47","pubTimestamp":1760813228,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，益丰药房报收于24.7元，较上周的24.51元上涨0.78%。本周，益丰药房10月13日盘中最高价报25.0元。益丰药房当前最新总市值299.47亿元，在医药商业板块市值排名2/32，在两市A股市值排名609/5158。本周关注点公司公告汇总：益丰药房决定不向下修正“益丰转债”转股价格，且未来3个月内如再次触发修正条件亦不修正。公司于2025年10月15日召开第五届董事会第二十三次会议，审议通过不向下修正“益丰转债”转股价格的议案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101900000510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0209","LU2148510915.USD","LU2460026573.USD","LU2488822045.USD","603939","LU1064130708.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2575673692","title":"益丰药房（603939）披露不向下修正“益丰转债”转股价格的公告，10月15日股价上涨0.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2575673692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575673692?lang=zh_cn&edition=full","pubTime":"2025-10-15 22:41","pubTimestamp":1760539270,"startTime":"0","endTime":"0","summary":"截至2025年10月15日收盘，益丰药房报收于24.14元，较前一交易日上涨0.12%，最新总市值为292.68亿元。公司近日发布公告称，自2025年9月17日至10月15日，益丰药房股票收盘价在连续三十个交易日内至少有十五个交易日低于当期转股价格31.84元/股的85%，已触发转股价格向下修正条款。公司于2025年10月15日召开第五届董事会第二十三次会议，审议通过不向下修正“益丰转债”转股价格的议案。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101500038465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU2488822045.USD","603939","BK0209","LU2460026573.USD","LU1064130708.USD","LU2148510915.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2571571346","title":"益丰药房（603939）披露2022年限制性股票激励计划预留授予第二个解除限售期解除限售条件成就公告，9月30日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2571571346","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2571571346?lang=zh_cn&edition=full","pubTime":"2025-09-30 18:23","pubTimestamp":1759227835,"startTime":"0","endTime":"0","summary":"近日，益丰大药房连锁股份有限公司发布《关于2022年限制性股票激励计划预留授予第二个解除限售期解除限售条件成就的公告》。本次符合解除限售条件的激励对象共29人，可解锁限制性股票数量为196,838股，占公司总股本的0.02%。公司预留授予的限制性股票第二个解除限售期已于2025年10月24日届满，公司2024年净利润较2021年增长71.98%，达到业绩考核目标。公司已办理相关解除限售申请手续，后续将发布股份上市公告。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20250930/31685476.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0209","LU1064130708.USD","LU2460026573.USD","603939","LU2488822045.USD","LU1064131003.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"2570928899","title":"每周股票复盘：益丰药房（603939）将召开2025年半年度业绩说明会","url":"https://stock-news.laohu8.com/highlight/detail?id=2570928899","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570928899?lang=zh_cn&edition=full","pubTime":"2025-09-28 02:17","pubTimestamp":1758997031,"startTime":"0","endTime":"0","summary":"截至2025年9月26日收盘，益丰药房报收于24.82元，较上周的25.22元下跌1.59%。本周，益丰药房9月24日盘中最高价报25.56元。本周关注点公司公告汇总：益丰药房将于2025年9月29日召开半年度业绩说明会，投资者可提前提交问题。公司公告汇总益丰药房关于召开2025年半年度业绩说明会的公告益丰大药房连锁股份有限公司将于2025年9月29日16:00-17:00通过上海证券交易所上证路演中心举行2025年半年度业绩说明会，以网络互动方式与投资者交流公司经营成果及财务状况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092800000515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU1064130708.USD","BK0209","603939","LU2488822045.USD","LU2460026573.USD","LU2148510915.USD"],"gpt_icon":0},{"id":"2569249602","title":"每周股票复盘：益丰药房（603939）益丰转债转股价格调整至31.84元","url":"https://stock-news.laohu8.com/highlight/detail?id=2569249602","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569249602?lang=zh_cn&edition=full","pubTime":"2025-09-21 05:28","pubTimestamp":1758403696,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，益丰药房报收于25.22元，较上周的25.76元下跌2.1%。本周，益丰药房9月18日盘中最高价报26.56元。本周关注点公司公告汇总：益丰转债转股价格因分红调整为31.84元/股，自2025年9月17日起生效。“益丰转债”因实施2025年半年度权益分派，每股派发现金红利0.30元（含税），转股价格由32.14元/股调整为31.84元/股。中信证券认为此次调整预计不会对公司生产经营和偿债能力产生重大不利影响，并将持续关注公司信用状况及债券事项。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092100001491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064130708.USD","LU2488822045.USD","BK0209","603939","LU2460026573.USD","LU2148510915.USD","LU1064131003.USD"],"gpt_icon":0},{"id":"2567587136","title":"每周股票复盘：益丰药房（603939）每股派息0.30元含税","url":"https://stock-news.laohu8.com/highlight/detail?id=2567587136","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2567587136?lang=zh_cn&edition=full","pubTime":"2025-09-14 04:42","pubTimestamp":1757796135,"startTime":"0","endTime":"0","summary":"截至2025年9月12日收盘，益丰药房报收于25.76元，较上周的24.87元上涨3.58%。本周，益丰药房9月9日盘中最高价报26.56元。本周关注点公司公告汇总：益丰药房2025年半年度每股派发现金红利0.30元（含税）。本次利润分配以公司总股本1,212,417,289股为基数，共计派发现金红利363,725,186.70元。因实施2025年半年度权益分派，益丰转债在2025年9月9日至9月16日停止转股，自9月17日起恢复转股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091400001072.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939","LU1064130708.USD","LU1064131003.USD","LU2488822045.USD","BK0209","LU2148510915.USD","LU2460026573.USD"],"gpt_icon":0},{"id":"2566215659","title":"研报掘金丨中银证券：维持益丰药房“买入”评级，看好公司的长期发展","url":"https://stock-news.laohu8.com/highlight/detail?id=2566215659","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2566215659?lang=zh_cn&edition=full","pubTime":"2025-09-12 16:06","pubTimestamp":1757664374,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["601696","BK0209","09939","LU1064130708.USD","159938","BK1574","LU1064131003.USD","160636","159792","BK1161","LU2460026573.USD","LU2148510915.USD","LU2488822045.USD","BK0276","603939","BK1515"],"gpt_icon":0},{"id":"2565501394","title":"益丰药房涨5.27%，中邮证券六日前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2565501394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565501394?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:23","pubTimestamp":1757319781,"startTime":"0","endTime":"0","summary":"今日益丰药房涨5.27%，收盘报26.18元。2025年9月2日，中邮证券研究员盛丽华,龙永茂发布了对益丰药房的研报《盈利能力持续提升，积极推进新零售体系建设》，该研报对益丰药房给出“买入”评级。研报中预计2025-2027年营业收入分别为255.44、281.40、310.80亿元，归母净利润分别为17.15、19.75、22.80亿元，当前股价对应PE分别为17、15、13倍，维持“买入”评级。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020524.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939","161027"],"gpt_icon":0},{"id":"2565589457","title":"东吴证券：给予益丰药房买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2565589457","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565589457?lang=zh_cn&edition=full","pubTime":"2025-09-05 07:32","pubTimestamp":1757028744,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,冉胜男,苏丰近期对益丰药房进行研究并发布了研究报告《2025年中报点评：盈利增长稳健，多渠道运营赋能长期发展》，给予益丰药房买入评级。 盈利预测与投资评级：考虑公司拓店放缓，我们将公司2025-2027年归母净利润由17.69/20.36/23.39调整为17.68/19.82/22.28亿元，对应当前市值的PE为17/15/13X，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有12家机构给出评级，买入评级8家，增持评级4家；过去90天内机构目标均价为33.39。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500005825.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601555","603939"],"gpt_icon":0},{"id":"2563833096","title":"每周股票复盘：益丰药房（603939）2025年中报净利增10.32%","url":"https://stock-news.laohu8.com/highlight/detail?id=2563833096","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563833096?lang=zh_cn&edition=full","pubTime":"2025-08-31 08:44","pubTimestamp":1756601052,"startTime":"0","endTime":"0","summary":"截至2025年8月29日收盘，益丰药房报收于23.74元，较上周的24.54元下跌3.26%。本周，益丰药房8月25日盘中最高价报24.53元。本周关注点业绩披露要点：2025年中报归母净利润8.8亿元，同比上升10.32%。股本股东变化：截至2025年6月30日股东户数为2.16万户，较上期增加7.7%。公司公告汇总2025年8月25日召开第二次临时股东会，出席股东及代理人共706人，持有表决权股份总数占公司总股本的74.5997%。益丰数字化平台升级项目完成日期由2025年7月31日延长至12月31日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083100002698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1064131003.USD","LU2148510915.USD","603939","BK0209","LU1064130708.USD","LU2488822045.USD","LU2460026573.USD"],"gpt_icon":0},{"id":"2563073220","title":"国金证券：给予益丰药房买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2563073220","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2563073220?lang=zh_cn&edition=full","pubTime":"2025-08-30 15:06","pubTimestamp":1756537599,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,王奔奔近期对益丰药房进行研究并发布了研究报告《业绩增长稳健，盈利质量继续提升》，给予益丰药房买入评级。同时，公司继续保持高盈利质量：1H25公司零售业务实现收入102.0亿元，同比-1.9%，毛利率为41.99%，同比+1.04pct。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级2家，增持评级1家；过去90天内机构目标均价为30.17。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025083000016162.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603939"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1766004096996,"stockEarnings":[{"period":"1week","weight":-0.048},{"period":"1month","weight":-0.1106},{"period":"3month","weight":-0.1504},{"period":"6month","weight":-0.07},{"period":"1year","weight":-0.1427},{"period":"ytd","weight":-0.078}],"compareEarnings":[{"period":"1week","weight":-0.0077},{"period":"1month","weight":-0.0256},{"period":"3month","weight":0.0101},{"period":"6month","weight":0.1519},{"period":"1year","weight":0.1514},{"period":"ytd","weight":0.1547}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"益丰大药房连锁股份有限公司","boardCode":"AI0052","boardName":"零售业","stockholders":"20230人(较上一季度减少6.41%)","perCapita":"59930股","listingDate":"2015-02-17","address":"湖南省常德市武陵区白马湖街道富强社区人民路2638号","registeredCapital":"121239万元","survey":" 益丰大药房连锁股份有限公司的主营业务是中西成药、中药饮片、医疗器械、保健食品、保健用品、个人护理用品以及与健康相关联的日化便利、家居清洁等商品的全渠道零售业务。公司的主要产品是中西成药、中药、非药品。","listedPrice":19.47},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"益丰药房(603939)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供益丰药房(603939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"益丰药房,603939,益丰药房股票,益丰药房股票老虎,益丰药房股票老虎国际,益丰药房行情,益丰药房股票行情,益丰药房股价,益丰药房股市,益丰药房股票价格,益丰药房股票交易,益丰药房股票购买,益丰药房股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"益丰药房(603939)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供益丰药房(603939)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}